Patient Preference and Adherence
Volume 12, 2018 - Issue
Open access
124
Views
30
CrossRef citations to date
0
Altmetric
Original Research
Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study
Séverine Vermeire1 Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium, [email protected]Correspondence[email protected]
, François D’heygere2 Department of Gastroenterology, AZ Groeninge, Kortrijk, Belgium
, Antoine Nakad3 Department of Gastroenterology, CHWAPI, Tournai, Belgium
, Denis Franchimont4 Department of Gastroenterology, Erasme Hospital, Brussels, Belgium
, Fernand Fontaine5 Department of Gastroenterology, CHC St Joseph, Liège, Belgium
, Edouard Louis6 Department of Gastroenterology, University Hospital CHU Sart Tilman, Liège, Belgium
, Philippe Van Hootegem7 Department of Gastroenterology, AZ St Lucas, Brugge, Belgium
, Olivier Dewit8 Department of Gastroenterology, UCL St Luc, Brussels, Belgium
, Guy Lambrecht9 Department of Gastroenterology, AZ Damiaan, Oostende, Belgium
, Beatrijs Strubbe10 Department of Gastroenterology, OLV Hospital, Aalst, Belgium
& Filip Baert11 Department of Gastroenterology, AZ Delta, Roeselare-Menen, Belgium
show all
Pages 1193-1202
|
Published online: 06 Jul 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.